Orexo AB (publ) (ORX.ST) Stock Price, News & Chart

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.4980

Open1.5140

Day range1.30001.6460

52-week range1.300036.0000

Off day high−12.03%

Off 52-week high−95.98%

Volume801.10K

Avg. volume (3M)151.18K

Market cap—

EPS (TTM)-13.08

Forward P/E—

P/E ratio (TTM)—

Dividend yield—

Beta (5Y)1.01

Shares outstanding—

Short interest—

Earnings dateOct 22, 2026

Analyst target26.5000

Profit margin3,152.80%

Against its peers

Compare in full ›

	ORX.ST	2M7C.F	AQST	42C.SI	INDV	AMPH
Market cap	—	2.87B	476.94M	515.12M	4.28B	1.19B
P/E (TTM)	—	14.8	—	—	10.2	16.6
Forward P/E	—	—	-6.7	247.4	8.0	8.8
Price/book	0.3	1.2	-6.7	33.6	-71.4	1.6
Dividend yield	—	3.42%	—	—	—	—
1-year change	−94.52%	−24.84%	−38.01%	+259.26%	−12.17%	+15.64%
Today	−3.34%	+2.61%	−2.06%	−3.09%	+2.57%	+3.32%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Orexo AB (publ)'s by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
China Medical System Holdings Limited2M7C.F · Drug Manufacturers - Specialty & Generic	2.87B	1.1800	+2.61%
Aquestive Therapeutics, Inc.AQST · Drug Manufacturers - Specialty & Generic	476.94M	3.8000	−2.06%
iX Biopharma Ltd.42C.SI · Drug Manufacturers - Specialty & Generic	515.12M	0.4700	−3.09%
Indivior Pharmaceuticals, Inc.INDV · Drug Manufacturers - Specialty & Generic	4.28B	36.28	+2.57%
Amphastar Pharmaceuticals, Inc.AMPH · Drug Manufacturers - Specialty & Generic	1.19B	28.02	+3.32%
Luye Pharma Group Ltd.LUP.F · Drug Manufacturers - Specialty & Generic	762.19M	0.1880	+3.87%
Medexus Pharmaceuticals Inc.MDP.TO · Drug Manufacturers - Specialty & Generic	158.39M	5.04	+1.41%
Aspen Pharmacare Holdings LimitedAPN.JO · Drug Manufacturers - Specialty & Generic	72.96B	16,854.00	+2.92%

Other companies in Drug Manufacturers - Specialty & Generic, closest in size first.

Company	Mkt cap	Price	Today
Takeda Pharmaceutical Company Limited4502.T · Chuo, Japan	11.00T	6,888.00	+4.55%
Yuhan Corporation000100.KS · Seoul, South Korea	6.18T	82,600.00	+5.63%
Hanmi Pharm. Co., Ltd.128940.KS · Hwaseong-si, South Korea	5.90T	465,000.00	+9.80%
Gedeon Richter PLC0QFP.IL · Budapest, Hungary	4.46T	12,914.88	+156.25%
Sun Pharmaceutical Industries LimitedSUNPHARMA.BO · Mumbai, India	4.38T	1,825.35	+2.78%
Divi's Laboratories LimitedDIVISLAB.BO · Hyderabad, India	2.69T	10,150.00	+1.14%
Shionogi & Co., Ltd.4507.T · Kita, Japan	2.72T	3,192.00	+5.42%
Hanall Biopharma Co., Ltd.009420.KS · Daejeon, South Korea	2.01T	39,450.00	+6.19%

Also based in Uppsala, Sweden, then elsewhere in Sweden.

Company	Mkt cap	Price	Today
Beijer Alma AB (publ)BEIA-B.ST · Uppsala, Sweden	18.77B	311.50	+2.13%
AAC Clyde Space AB (publ)AAC.ST · Uppsala, Sweden	833.68M	102.00	−0.58%
C-Rad AB (publ)CRAD-B.ST · Uppsala, Sweden	795.54M	24.20	+1.68%
Unibap Space Solutions AB (publ)UNIBAP.ST · Uppsala, Sweden	709.91M	9.82	+1.66%
OssDsign AB (publ)OSSD.ST · Uppsala, Sweden	419.27M	3.7900	+5.28%
Metacon AB (publ)META.ST · Uppsala, Sweden	146.88M	0.0839	+2.32%
Klaria Pharma Holding AB (publ.)KLAR.ST · Uppsala, Sweden	129.14M	0.5250	−3.31%
Spotify Technology S.A.SPOTN.MX · Stockholm, Sweden	2.38T	11,600.00	+3.77%

Companies that serve the same markets: healthcare, life sciences, devices.

Company	Mkt cap	Price	Today
HLS Therapeutics Inc.HLS.TO · devices · life sciences · healthcare	131.47M	4.2500	+0.47%
Aytu BioPharma, Inc.AYTU · devices · life sciences · healthcare	20.86M	1.9200	−0.52%
Teva Pharmaceutical Industries LimitedTEVA · devices · life sciences · healthcare	48.81B	41.85	−0.14%
Mercury Laboratories LimitedMERCURYLAB.BO · devices · life sciences · healthcare	957.60M	798.00	+4.99%
Golden Throat Holdings Group Company Limited6896.HK · devices · life sciences · healthcare	1.45B	1.960	−2.00%
Bajaj HealthCare LimitedBAJAJHCARE.NS · devices · life sciences · healthcare	10.77B	320.05	+3.71%
Fredun Pharmaceuticals LimitedFREDUN.BO · devices · life sciences · healthcare	25.51B	1,493.45	−1.07%
Cian Healthcare LimitedCHCL.BO · devices · life sciences · healthcare	888.00M	35.52	+1.98%

What visitors to Orexo AB (publ)'s page also look at.

Company	Mkt cap	Price	Today
BioInvent International ABBINV.ST	245.45M	3.7300	+4.04%
Swedish Orphan Biovitrum ABSOBI.ST	171.98B	494.20	+2.40%
Camurus ABCAMX.ST	43.03B	723.00	+8.72%
BioArctic AB ser. BBIOA-B.ST	27.72B	312.40	+2.23%
Active Biotech ABACTI.ST	101.09M	3.8350	+4.21%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All ORX.ST news ›

Seeking Alpha·Oct 24

Orexo AB (publ) 2026 Q3 - Results - Earnings Call Presentation

2026-10-24. The following slide deck was published by Orexo AB (publ) in conjunction with their 2026 Q3 earnings call. The following slide deck was published by Orexo AB (publ) in conjunction with their 2026 Q3 earnings call.

Mugglehead·Oct 6Negative

Orexo AB (publ) proposes SEK250M rights issue ahead of drug milestones

Orexo expects to announce final issue terms preliminarily on Nov. 3 and plans a shareholder vote for Nov. 6. An approximately SEK250 million rights issue would finance drug development and a possible U.S. Justice Department settlement…

ELOX LLY ADRX NVO

TradingView·Oct 6Positive

Orexo AB (publ) (ORX) Plans SEK 250M Rights Issue, 70% Backstopped

TradingView Orexo AB (publ) (ORX) Plans SEK 250M Rights Issue, 70% Backstopped Orexo AB (publ) will conduct a rights issue of approximately SEK 250M, subject to EGM approval, with about 70% covered by subscriptions and underwriting.

IX SFTBF RXO

TradingView·Oct 6Positive

Orexo AB (publ) (ORX) Calls EGM to Approve Shareholder Rights Issue

TradingView Orexo AB (publ) (ORX) Calls EGM to Approve Shareholder Rights Issue Orexo will hold an EGM on Nov 6, 2026 to amend articles and approve a rights issue to strengthen finances, fund prioritized development, an expected DO

DGNX

From the 4Search news index, newest first.

In the news

5mentions in 30 days

5with it in the headline

Positivesentiment

Most coverage from

seekingalpha.com2
tradingview.com2
mugglehead.com1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.